文献速递头颈部肿瘤放疗放疗物理与技术

AKT抑制作为靶向缺氧HPV阳性头颈鳞癌的策略

AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC.
PubMed 文献 · Radiother Oncol · 2020-04-30

研究在9株HPV阴性和4株HPV阳性头颈鳞癌细胞系中评估缺氧下AKT激活及AKT抑制剂MK2206对放疗敏感性的影响;结果显示缺氧激活AKT,AKT抑制在缺氧条件下抑制细胞生长更有效,并能特异性逆转HPV阳性细胞的缺氧相关放射抵抗。

要点

  • 缺氧在HPV阴性和阳性头颈鳞癌细胞系中均激活AKT,可被MK2206阻断。
  • AKT抑制在缺氧条件下比常氧下更有效地抑制所有头颈鳞癌细胞生长。
  • AKT抑制能特异性逆转HPV阳性细胞由缺氧导致的放射抵抗。

核心结论

  • 头颈鳞癌肿瘤依赖AKT在缺氧下存活,靶向AKT可能克服缺氧诱导的放射抵抗,尤其在HPV阳性头颈鳞癌中。

研究设计与样本

  • 研究纳入9株HPV阴性和4株HPV阳性头颈鳞癌细胞系,用western blot评估AKT激活,用CCK8法和克隆形成实验评估缺氧孵育、AKT抑制和/或照射后的存活。

主要发现

  • 缺氧在HPV阴性和阳性细胞系中均激活AKT,MK2206可消除该激活。
  • HPV阳性细胞系在常氧下对MK2206高度敏感。
  • 在所有头颈鳞癌细胞系中,AKT抑制在缺氧条件下抑制细胞生长的效果显著优于常氧条件。
  • 缺氧显著降低放射敏感性,与HPV状态无关,但仅在HPV阳性细胞中可被AKT抑制有效逆转。

临床怎么用

  • 对缺氧的HPV阳性头颈鳞癌,可考虑将AKT抑制作为放疗增敏的潜在策略,但尚需临床验证。

局限性

  • 证据仅来自细胞系实验,未涉及动物模型或临床样本,结论需进一步体内和临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Hypoxia negatively affects treatment outcome in both Human papillomavirus (HPV)-positive and -negative head and neck squamous cell carcinomas (HNSCC). Despite HPV-positive patients having a relatively good prognosis, hypoxic HPV-positive tumours are associated with poor treatment outcome, and do not respond to hypoxia modification. Earlier, we showed that hypoxia induces the pro-survival AKT pathway. In this study, we aim to investigate whether AKT inhibition affects the response to radiotherapy under hypoxia, and determine whether this is a viable treatment strategy for HNSCC patients with hypoxic HPV-positive tumours. MATERIALS AND METHODS: Nine HPV-negative and 4 HPV-positive HNSCC cell lines were characterized. AKT activation was assessed by western blot. Survival in response to hypoxic incubation, AKT inhibition and/or irradiation was assessed using CCK8 assays and colony forming assays. RESULTS: AKT was activated under hypoxia in both HPV-negative and -positive cell lines, which could be abrogated by the AKT inhibitor MK2206. HPV-positive cell lines were highly sensitive to MK2206 at normoxia. In all HNSCC cell lines, AKT inhibition was significantly more effective in inhibiting cell growth during hypoxic conditions than under normoxia. Hypoxia significantly reduced radiosensitivity irrespective of HPV-status, yet specifically in HPV-positive cells this could be efficiently reversed by AKT inhibition. CONCLUSIONS: These data suggest that HNSCC tumours are dependent on AKT to survive hypoxia, and that AKT inhibition is specifically effective in radioresistant hypoxic HPV-positive cells. Targeting AKT may thus be a potential way to overcome hypoxia induced radioresistance, particularly in HPV-positive HNSCC tumours.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Göttgens EL, Bussink J, Ansems M, et al. AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC. Radiother Oncol. 2020. PMID: 32361013. doi:10.1016/j.radonc.2020.04.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。